Tag: biosimilars pipeline
A Biopharmaceutical CROs Market, By Roots Analysis
Most of the deals reported in the public domain are licensing and commercialization agreements
0
0
0
22 Jul, 10:01 AM
Biopharmaceutical CROs Market, By Roots Analysis
Most of the deals reported in the public domain are licensing and commercialization agreements
0
0
0
20 Jul, 05:10 AM
Biosimilars market is projected to witness considerable growth over the coming years, claims Roots Analysis
Being one of the first biologics against anti-inflammatory diseases, HUMIRA® is considered an aberration in terms of patent protection.
0
0
0
5 Jul, 04:59 AM
